Extrawell Pharmaceutical Grants 92 Million Share Options
Stock News
Oct 21
Extrawell Pharmaceutical Holdings Ltd (00858) has announced the granting of share options to three directors and one service provider.
The company stated that on October 21, 2026, it granted share options to three directors, namely Dr. Xie Yi, Ms. Wang Xiujuan, and Mr. Wu Xiangyun, as well as one service provider, Dr. Mao Yumin.
The share options will entitle the grantees to subscribe for a total of 92 million ordinary shares of HK$0.01 each in the company's share capital, with an exercise price of HK$0.0726 per share.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.